Trial intelligence / Profile preview

Adherence With Iron Sprinkles Among High-Risk Infants

NCT00136266Phase 3Completed

Sponsor
Centers for Disease Control and Prevention
Start
Mar 2005
Primary completion
Dec 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ferrous fumarate in iron deficiency anemia (IDA), anemia, sponsored by Centers for Disease Control and Prevention. Started Mar 2005; status: completed.

02

Drugs

ferrous fumarate
03

Conditions

iron deficiency anemia (IDA)anemia

Beyond the preview

Go deeper on NCT00136266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00136266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call